Line 268: |
Line 268: |
| {| class="wikitable" | | {| class="wikitable" |
| |- | | |- |
− | ! ADULT TUMOR | + | ! TUMOR |
| ! SUBTYPES | | ! SUBTYPES |
| ! BROAD ABERRATIONS (>10Mb) | | ! BROAD ABERRATIONS (>10Mb) |
Line 300: |
Line 300: |
| |Adults and pediatric tumors show similar CNVs; CDKN2A/CDKN2B loss may correlate with anaplastic histology | | |Adults and pediatric tumors show similar CNVs; CDKN2A/CDKN2B loss may correlate with anaplastic histology |
| |PMID:23442159; PMID:28181325 | | |PMID:23442159; PMID:28181325 |
| + | |- |
| + | | |
| + | |Ganglioglioma |
| + | |'''Gain:''' polysomy 5, polysomy 7, 10p<br> |
| + | '''Loss:''' 1p loss, monosomy (with focal CDKN2A loss) |
| + | |'''Mutation:''' BRAF V600E , TSC1, TSC2, FGFR1, FGFR2, KRAS |
| + | |Generally indolent tumors; surgical resection can be curative |
| + | |PMID:23442159; PMID:25764012; PMID:29880043 |
| + | |- |
| + | | |
| + | |Angiocentric glioma |
| + | |'''Loss:''' 6q24-q25 |
| + | |'''Fusion:''' MYB-QKI rearrangement/deletion (classic histology)<br> |
| + | '''Rearrangement:''' MYB alone (atypical histology)<br> |
| + | '''Amplification:''' MYB (atypical histology) |
| + | |Generally indolent tumors; surgical resection can be curative |
| + | |PMID:26829751 |
| + | |- |
| + | | |
| + | |Dysembryoplastic neuroepithelial tumor (DNET) |
| + | |No specific changes |
| + | |'''Mutation:''' intragenic duplication or mutation FGFR1; BRAF V600E |
| + | |Rare in adults; Benign with excellent prognosis even with subtotal resection |
| + | |PMID:26920151; PMID:23442159; PMID:21937911 |
| + | |- |
| + | | |
| + | |Rosette forming glioneuronal tumor |
| + | |'''Gain:'''1q , 7, 9, 16<br> |
| + | '''Loss:''' 1p<br> |
| + | '''Amplification:''' 9q34.2, 19p13.3 |
| + | |'''Fusion:''' KIAA1549-BRAF fusion (via 3'BRAF duplication)<br> |
| + | '''Mutation:''' PIK3CA, FGFR1<br> |
| + | '''Amplification:''' SBNO2 |
| + | |Generally indolent tumors; surgical resection can be curative |
| + | |PMID:27893178; PMID:26371886 |
| + | |- |
| + | |Infiltrating Gliomas |
| + | |- |